V3YL:XETRA:XETRA-Vanguard ESG North America All Cap UCITS ETF USD Income EUR (EUR)

ETF | Others |

Last Closing

USD 5.56

Change

+0.01 (+0.23)%

Market Cap

USD 0.14B

Volume

4.59K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.85 (-1.66%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.13 (-0.80%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.20 (-0.76%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.31 (-1.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.18 (-0.76%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+2.06 (+1.36%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-0.66 (-0.47%)

USD 105.05B
JARI:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.35%)

USD 102.57B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.43 (-0.86%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.36 (+0.26%)

USD 80.38B

ETFs Containing V3YL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.36% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.36% 72% C 71% C-
Trailing 12 Months  
Capital Gain 28.02% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.02% 85% B 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.65% 67% D+ 65% D
Dividend Return 7.65% 66% D+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.84% 54% F 63% D
Risk Adjusted Return 64.60% 81% B- 82% B
Market Capitalization 0.14B 41% F 37% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.